Explore Our Network

4M Therapeutics is a biotechnology company specializing in the discovery and development of targeted therapies for neuropsychiatric and neurodegenerative diseases such as bipolar disorder and Alzheimer's disease. Leveraging a human brain cell platform derived from induced pluripotent stem cells, the company advances small molecule and peptide drug candidates that modulate pathways involved in neuronal health. 4M Therapeutics integrates biomarker-driven drug development and strong academic collaborations to enable predictive and safe preclinical drug discovery, aiming to advance targeted CNS therapies with improved safety and efficacy profiles.

Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.

Alithia Life Sciences is an Australian-owned, boutique, full-service Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, device companies, and institutional research groups with their projects in Australia and beyond. With over 25 years of operational expertise across a wide range of therapeutic areas, Alithia offers personalized project management from Phase I to Phase III, aiming to deliver efficient project outcomes, add value to client programs, and ultimately improve human health and wellbeing.

Apertur develops an app-based solution that assesses brain health through real-time analysis of pupillary dynamics using the smartphone camera. The approach provides metrics and patterns to track and potentially enhance brain performance, supporting individuals in monitoring and optimizing their mental state. In addition, Apertur develops a traumatic brain injury in the moment diagnostic app that leverages the same core technology.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

Athari BioSciences is a CLIA-certified BSL-2 diagnostic, research, and training laboratory advancing healthcare through scientific innovation in diagnostics, therapeutics, genomic research, and workforce development. With a mission focused on improving health equity, personalized medicine, and education, the company provides laboratory, research, and regulatory services, and offers hands-on learning experiences to foster the next generation of life sciences professionals.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, analysis, implementation, and software solutions for the pharmaceutical and medical device industry. They focus on adaptive clinical trials and Bayesian analysis, aiming to improve the efficiency and effectiveness of clinical research.

BioBridge Global is a nonprofit organization dedicated to saving and enhancing lives through the healing power of human cells and tissue. It operates a family of nonprofits including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and The Blood & Tissue Center Foundation. The organization provides lifesaving therapies to patients and supports advances in advanced therapies, focusing on blood, cell, and tissue products, testing services, and the development of new therapies.

BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

BrightFocus Foundation is a leading nonprofit organization dedicated to funding innovative scientific research and providing expert information to defeat Alzheimer’s disease, macular degeneration, and glaucoma. With a mission to envision a world where everyone can age free from diseases of mind and sight, BrightFocus invests in groundbreaking research, supports the next generation of scientists, and empowers individuals and families with trusted resources. Over its 50-year history, the foundation has awarded nearly $300 million in research grants to more than 6,000 scientists worldwide, catalyzing life-changing breakthroughs and advancing public education on brain and vision health. The foundation's impact is evident in major scientific milestones, such as the first successful cell transplantation for glaucoma, FDA "Breakthrough Therapy" designations, and the development of new diagnostic and therapeutic approaches for neurodegenerative and vision diseases.

CA Analytical Testing Services is an FDA inspected contract laboratory and drug development partner providing integrated analytical, microbiological, formulation, and CMC support across the product lifecycle. We can integrate directly into development programs to provide analytical method development, microbiological support, formulation and characterization activities, and problem-solving throughout early- and late-stage development. Beyond laboratory testing, CA Analytical can support broader drug and medical device programs through CDMO selection and qualification, technology transfer, third-party quality and manufacturing oversight, regulatory support, QC release testing, and stability programs. Our team can function as an extension of a sponsor's internal development and quality organization, helping coordinate technical activities across multiple external partners. CA Analytical is also building an internal drug product portfolio that includes small-molecule and liposomal formulations. We are particularly interested in partnering with organizations developing novel or alternative drug-delivery technologies that can be combined with existing or emerging therapeutics to improve delivery, durability, usability, and ultimately advance medicines toward clinical application.

Caleo Biotechnologies develops patient-derived human translational models for preclinical therapeutic development. Our proprietary Organ-Dish™ platform generates multicellular 3D tissue models directly from human biospecimens while preserving key epithelial, stromal/mesenchymal, and immune compartments and features of native tissue biology. The platform enables evaluation of therapeutic efficacy, tissue injury and repair, inflammation, immune response, fibrosis and remodeling, and translational biomarkers in a patient-relevant human system. Organ-Dish™ models are scalable and compatible with pharmacologic, biologic, and cell-based therapeutic testing and downstream molecular and histologic analyses. Our approach aligns with the FDA’s increasing emphasis on human-relevant New Approach Methodologies (NAMs) to strengthen preclinical evidence and reduce reliance on animal testing. CaleoBio is interested in partnerships with therapeutic developers, biotechnology companies, academic investigators, and government/DoD teams seeking human translational models to support preclinical R&D and therapeutic development. Current and expanding applications include gastrointestinal disease, traumatic and complex wounds, pulmonary fibrosis, liver disease, and oncology.

Case Western Reserve University is dedicated to solving the biggest issues of today and tomorrow through innovative research and education. With a commitment to experiential learning, the university offers a wide range of programs and opportunities for students to engage in research, internships, and community service, all within a vibrant campus located in Cleveland, Ohio.

CatalystBio is a global advisory firm focused on the life sciences sector, providing integrated end-to-end consulting services to biotechnology companies. The firm specializes in advancing product development from initial discovery through regulatory approval, offering strategic direction and operational execution to help organizations achieve critical milestones efficiently. Services span regulatory affairs, CMC, quality, preclinical and clinical development, diligence, fundraising, and company buildout.

Chronic Trace develops a research-stage platform that turns video from a commodity smartphone into objective, baseline-relative indices of brain function. A single short capture fuses involuntary signals (oculomotor and postural) with task-based measures (cognitive and reaction) into one calibrated index, the Trace Score, for decision support. The live focus today is concussion and mild TBI; the same architecture is patent-staked to extend toward stroke triage, psychiatric, and neurodegenerative monitoring. The platform is in active validation, backed by 15 U.S. patents pending, with encrypted data handling at rest and in transit. It is decision-support and research-stage, not a cleared medical device, and its outputs are intended for interpretation by qualified health professionals.

Clear Choice Therapeutics specializes in advanced wound care, with a focus on negative pressure wound therapy (NPWT) systems designed by orthopedic surgeons for both civilian and military applications. The company has developed FDA-cleared dressing kits and contact layers using proprietary transparent thermoplastic elastomer materials. Its NPWT solutions emphasize efficient fluid evacuation, enhanced wound visualization, reduced pain during dressing changes, and decreased infection risk—offering improvements over traditional foam-based wound therapies. The PREVENT allows for Low Pressure Wound Therapy (-50mmHg) which avoids high suction levels. Traditional foam NPWT can result in high downward forces on wounds resulting in decreased tissue perfusion and delayed healing.

Clinical Research Strategies (CRS) is a Pittsburgh-based contract research organization and executive management consultancy dedicated to improving the performance of start-up and mid-size life sciences companies. With a focus on instilling fiscal discipline and reducing risks in clinical development, corporate affairs, and quality assurance programs, CRS provides tailored consulting and staffing solutions to navigate the complexities of regulatory pathways and ensure successful product launches. CRS is also committed to leveraging advancements in artificial intelligence and machine learning to enhance clinical research and regulatory processes.

The Coalition for National Trauma Research (CNTR) is dedicated to saving lives and reducing disability through trauma research. Their mission focuses on coordinating research efforts, strengthening infrastructure for multi-center investigations, and advocating for sustainable research funding to address the burden of traumatic injuries.